The Food and Drug Administration has riled to limit the Johnson & Johnson COVID vaccine use on Thursday.
FDA said the move is needed since the Johnson & Johnson vaccine was tied to 60 cases of a rare blood clotting disease called thrombosis with thrombocytopenia syndrome.
The FDA added that nine people have already died from TTS caused by the vaccine.
FDA said, for now, the Johnson & Johnson vaccine is only recommended for people who cannot access another vaccine or people who have conditions that make the mRNA vaccines developed by Pfizer and Moderna more dangerous.
Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, explained their actions reflect their updated analysis of the risk of TTS following administration of this vaccine and limit the use of the vaccine to specific individuals.
Based on the latest data, only about 18 million Johnson & Johnson vaccine doses have been administered, compared to 340 million doses of the Pfizer vaccine and 217 million doses of the Moderna vaccine.